Male fertility start-up closes £2.5m seed funding round

Male fertility start-up ExSeed Health has closed a £2.5m seed extension round led by Ascension, with participation from Trifork, international investment firm Hambro Perks and R42 Group. ExSeed’s smartphone-based, at-home sperm testing kit guarantees patients over 95% accuracy – in line with traditional fertility clinics. It was approved by the British Standards Institute last year,…

You must be a HM Subscriber to view this content.

Subscribe Now »